The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article).
Medicine (Baltimore)
; 98(51): e18510, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31861037
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Hidroximetilglutaril-CoA Redutases
/
Aterosclerose
/
LDL-Colesterol
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article